Abstract
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.
Cite
CITATION STYLE
Schaeffer, E. M., Srinivas, S., Adra, N., An, Y., Bitting, R., Chapin, B., … Freedman-Cass, D. A. (2024). Prostate Cancer, Version 3.2024. Journal of the National Comprehensive Cancer Network, 22(3), 140–150. https://doi.org/10.6004/jnccn.2024.0019
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
